700 patients110,866 observations180 daysLIVE

Patient P-02029

Synthetic patientMETA-24 · Day 177 · 45–54 · F · baseline S18Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
52%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S18
  2. Day 21 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 21.

Primary contributors, last 14 days
  • Toxicity-14
  • Inflammatory activity-8
  • Treatment adherence+8
  • Nutritional resilience-6
  • GI instability-2

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    65%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 88% showed improvement
    • median effect visible after 8 days

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    61 min
    stable · +1.1 vs previous 14 d
    Sleep duration
    Wearable
    6.2 h
    stable · +0.1 vs previous 14 d
    Energy level
    Daily log
    2.7/10
    improving · +0.3 vs previous 14 d
    Steps
    Wearable
    7,616
    stable · +287 vs previous 14 d
    GI burden
    Companion
    58.7/100
    stable · +0.9 vs previous 14 d
    Adherence
    Companion
    71.9 %
    stable · -0.5 vs previous 14 d
    Sleep quality
    Wearable
    23/100
    improving · +1.3 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    144 mg/dL
    stable · -0.9 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 35 from the failing basin, 59 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +11.8
    • Protein
      supporter · GI -6.3 next day
    Main detractors to watch
    • Low butyrate capacity
      hidden · steering -17.5
    • FUT2 non-secretor
      hidden · steering -10.6
    • Dietary fat load
      perturbation · steering -9.2
    • Histamine load
      perturbation · steering -8.9
    • Histamine load
      detractor · GI +5.2 next day
    • Ultra-processed food
      detractor · GI +5 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -6.3supporter · 95%
    • Histamine load
      +5.2detractor · 95%
    • Ultra-processed food
      +5detractor · 95%
    • Dietary fat load
      +4.9detractor · 95%
    • Simple carbohydrates
      +3.9detractor · 90%
    • Insoluble fibre
      -2.4no signal · 46%
    • Caffeine
      +0.3no signal · 15%
    • Alcohol
      +0.1no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 80
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 59 and rising
    • Butyrate / short-chain fatty acid production 80
      • MicrobiomeButyrate capacity 29/100
      • MicrobiomeF. prausnitzii depleted
      • Daily logFibre intake low in recent food logs
    • Inflammatory signalling 65
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • BloodInflammatory load index 59
      • WearableHRV 32 ms, trending down
    • Autonomic recovery 45
      • WearableResting HR 79 bpm
      • WearableShort sleep window
    • Drug metabolism and exposure 20
      • BloodToxicity index 46
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    • GLP1R rs6923761 A
      Altered receptor sensitivity
    Microbiome
    Shannon diversity 2.6 · butyrate capacity 29/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    29 ms
    Sleep
    6.3 h
    Steps
    7,617
    Resting HR
    79 bpm
    Daily log: GI score 59, nutritional resilience 33, adherence 72.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0204822%S0277
    P-0211524%S14GI-04improved75
    P-0238821%S1175
    P-0257525%S14ME-01improved73
    P-0240322%S0371
    P-0233521%S0470
    P-0255023%S0170
    P-0219222%S0569
    P-0265928%S0969
    P-0235621%S0869
    P-0229321%S15HY-01no change68
    P-0259144%S1368